Form 4 for ATEC Alphatec Holdings, Inc.

Accepted 2023-05-12 00:00:00 ET · period of report 2023-05-10 · accession 0000899140-23-000630 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2023-05-12	2023-05-10	ATEC	Segal Paul	10%	S - Sale	$14.88	-1.70M	11.08M	-13%	-$25.30M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-05-10	S	D	1,700,000	$14.88	11,081,538	D	—	—	(F1) This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.88 to $15.67, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. (F4) Paul Segal separately is the direct beneficial owner of 171,329 shares of Common Stock of the Issuer. (F2) Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. (F3) Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.